Clinical Trial Update: Study of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status; Substudy-01 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a novel treatment combination in head and neck squamous cell carcinoma; study status is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Novel treatment combination therapies

Snippet

Sponsor: Gilead Sciences | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING